Published in Front Oncol on October 16, 2014
Antioxidants in Translational Medicine. Antioxid Redox Signal (2015) 2.32
Entacapone is an Antioxidant More Potent than Vitamin C and Vitamin E for Scavenging of Hypochlorous Acid and Peroxynitrite, and the Inhibition of Oxidative Stress-Induced Cell Death. Med Sci Monit (2016) 0.76
The role of vitamin C in the treatment of pain: new insights. J Transl Med (2017) 0.75
The acute effect of high-dose intravenous vitamin C and other nutrients on blood pressure: a cohort study. Blood Press Monit (2016) 0.75
Effect of Oral Coadministration of Ascorbic Acid with Ling Zhi Preparation on Pharmacokinetics of Ganoderic Acid A in Healthy Male Subjects: A Randomized Crossover Study. Biomed Res Int (2016) 0.75
Chemotherapy and Functional Medicine in a Patient With Metastatic Breast Cancer: A Case Report. Integr Med (Encinitas) (2016) 0.75
The role of quercetin and vitamin C in Nrf2-dependent oxidative stress production in breast cancer cells. Oncol Lett (2017) 0.75
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med (2010) 7.31
Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med (2004) 4.30
The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact (1974) 3.91
Placebo interventions for all clinical conditions. Cochrane Database Syst Rev (2010) 3.45
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27
A multidimensional measure of fatigue for use with cancer patients. Cancer Pract (1998) 2.84
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol (2008) 2.27
Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr (1999) 1.97
Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J (1999) 1.94
Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med (2009) 1.94
Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One (2010) 1.92
High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med (2014) 1.91
Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain. Clin J Pain (2009) 1.90
The cancer patient and quality of life. Oncologist (2002) 1.89
Is vitamin C supplementation beneficial? Lessons learned from randomised controlled trials. Br J Nutr (2009) 1.89
Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta (2012) 1.89
The biochemical functions of ascorbic acid. Annu Rev Nutr (1986) 1.68
The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage (2009) 1.53
Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr (1991) 1.36
Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun (2012) 1.36
Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol (2011) 1.36
Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One (2012) 1.35
Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal (2011) 1.34
Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol (2013) 1.33
World Health Organization guidelines for cancer pain: a reappraisal. Ann Oncol (2005) 1.12
Patterns of fatigue during a course of chemotherapy: results from a multi-centre study. Eur J Oncol Nurs (2006) 1.10
Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med (2012) 1.09
Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol (2013) 1.07
Mechanisms of ascorbic acid stimulation of norepinephrine synthesis in neuronal cells. Biochem Biophys Res Commun (2012) 1.06
Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer (2012) 1.06
Vitamin C deficiency in cancer patients. Palliat Med (2005) 1.05
Changes of terminal cancer patients' health-related quality of life after high dose vitamin C administration. J Korean Med Sci (2007) 1.04
Using QALYs in cancer: a review of the methodological limitations. Pharmacoeconomics (2011) 1.03
Intravenous vitamin C in the treatment of shingles: results of a multicenter prospective cohort study. Med Sci Monit (2012) 1.02
Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics. Antioxid Redox Signal (2013) 0.97
Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate. Int J Vitam Nutr Res Suppl (1982) 0.96
Evaluation of oxidative stress, antioxidant status and serum vitamin C levels in cancer patients. Biol Trace Elem Res (2009) 0.91
Intravenous Vitamin C and Cancer: A Systematic Review. Integr Cancer Ther (2014) 0.90
Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients. J Transl Med (2013) 0.90
Review article: a systematic review of cancer-related fatigue measurement questionnaires. Am J Hosp Palliat Care (2010) 0.90
Review of high-dose intravenous vitamin C as an anticancer agent. Asia Pac J Clin Oncol (2014) 0.87
Laying to rest psychostimulants for cancer-related fatigue? J Clin Oncol (2014) 0.87
A strategy for controlling potential interactions between natural health products and chemotherapy: a review in pediatric oncology. J Pediatr Hematol Oncol (2007) 0.83
Relief from cancer chemotherapy side effects with pharmacologic vitamin C. N Z Med J (2014) 0.79
Parenteral vitamin C for palliative care of terminal cancer patients. N Z Med J (2014) 0.79
Empirical criteria for the selection of quality-of-life instruments for the evaluation of peripheral blood progenitor cell transplantation. Int J Technol Assess Health Care (1998) 0.77
Consumption of vitamin C is below recommended daily intake in many cancer patients and healthy volunteers in Christchurch. N Z Med J (2014) 0.76